Your browser is no longer supported. Please, upgrade your browser.
DXCM DexCom, Inc. monthly Stock Chart
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-1.94 Insider Own0.90% Shs Outstand91.30M Perf Week5.19%
Market Cap19.02B Forward P/E119.27 EPS next Y1.75 Insider Trans-19.97% Shs Float91.10M Perf Month33.00%
Income-171.70M PEG- EPS next Q0.71 Inst Own- Short Float6.01% Perf Quarter27.37%
Sales1.35B P/S14.08 EPS this Y-324.80% Inst Trans2.70% Short Ratio5.83 Perf Half Y75.88%
Book/sh8.37 P/B24.89 EPS next Y28.08% ROA-8.40% Target Price206.31 Perf Year50.09%
Cash/sh15.66 P/C13.30 EPS next 5Y78.00% ROE-24.60% 52W Range105.05 - 208.20 Perf YTD73.93%
Dividend- P/FCF373.76 EPS past 5Y-28.10% ROI-11.10% 52W High0.08% Beta0.65
Dividend %- Quick Ratio5.30 Sales past 5Y45.20% Gross Margin63.30% 52W Low98.35% ATR8.33
Employees2800 Current Ratio5.60 Sales Q/Q48.60% Oper. Margin-9.20% RSI (14)79.25 Volatility3.76% 3.90%
OptionableYes Debt/Eq1.39 EPS Q/Q-3.10% Profit Margin-12.70% Rel Volume1.24 Prev Close202.81
ShortableYes LT Debt/Eq1.39 EarningsNov 06 AMC Payout- Avg Volume938.78K Price208.37
Recom1.60 SMA2024.23% SMA5031.26% SMA20044.24% Volume1,167,183 Change2.74%
Nov-07-19Upgrade Guggenheim Neutral → Buy
Nov-07-19Reiterated Canaccord Genuity Buy $185 → $195
Oct-23-19Initiated Stifel Buy
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Nov-15-19 09:38AM  San Gorgonio Hospital Picks Allscripts Sunrise Community Care Zacks
Nov-14-19 01:50PM  Growth Stocks And How To Find Big Stock Market Winners: Try This Blue Dot List In MarketSmith Investor's Business Daily
01:31PM  Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
10:38AM  5 Companies Hit 52-Week Highs GuruFocus.com
08:08AM  NextGen's Medfusion Buyout to Improve Patient Experience Zacks
03:19AM  Dexcom Looks Poised to Build on Its Big Gap Up TheStreet.com
Nov-13-19 06:04AM  5 Relative Price Strength Stocks to Buy for Optimum Returns Zacks
01:25AM  Edited Transcript of DXCM earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
08:14AM  The Zacks Analyst Blog Highlights: Dexcom, Fortinet and Agnico Eagle Zacks
Nov-11-19 10:00AM  What Makes DexCom (DXCM) a Strong Momentum Stock: Buy Now? Zacks
Nov-08-19 09:25AM  DexCom (DXCM) Soars to 52-Week High, Time to Cash Out? Zacks
09:11AM  DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3 Zacks
09:00AM  Dexcom Announces Upcoming Conference Presentation Business Wire
08:14AM  The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga
Nov-07-19 04:39PM  IBD Stock Of The Day Breaks Out To Record High After Crushing Earnings Views Investor's Business Daily +27.16%
01:59PM  Dow Jones Soars 858 Points In Q4; Why This Market Leader Surpassed An Alternate Buy Point Investor's Business Daily
Nov-06-19 04:03PM  Dexcom Reports Third Quarter 2019 Financial Results Business Wire
Nov-01-19 10:23AM  DexCom (DXCM) to Report Q3 Earnings: What's in the Offing? Zacks
Oct-22-19 04:26AM  3 Under the Radar Growth Stocks Investopedia
Oct-15-19 01:25PM  DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump TheStreet.com
Oct-12-19 04:56PM  Here is What Hedge Funds Think About DexCom, Inc. (DXCM) Insider Monkey
09:55AM  Is DexCom (NASDAQ:DXCM) Weighed On By Its Debt Load? Simply Wall St.
Oct-10-19 08:00AM  Dexcom CEO Kevin Sayer Rallies Employees Around A Noble Mission Investor's Business Daily
Oct-09-19 04:47PM  Dexcom Schedules Third Quarter 2019 Earnings Release and Conference Call for November 6, 2019 at 4:30 p.m. Eastern Time Business Wire
10:31AM  DexCom's (DXCM) New G6 Pro CGM System Gets FDA Approval Zacks
Oct-08-19 08:30AM  Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM Business Wire -5.67%
Oct-07-19 04:24PM  Why This High-Ranking Medical Stock Can't Seem To Get Traction Investor's Business Daily
Sep-27-19 06:52PM  Stocks & ETF to Invest in Healthcare Robotics and Innovation Zacks
Sep-23-19 05:03PM  Stocks & ETF to Invest in Healthcare Robotics and Innovation Zacks
Sep-20-19 09:56AM  CGM Devices Gain Steam, Set New Trend in Diabetes Management Zacks
Sep-17-19 04:05PM  Dexcom Promotes Quentin Blackford to Chief Operating Officer Business Wire
08:30AM  Dexcom Appoints Bridgette Heller to Board of Directors Business Wire
Sep-13-19 09:13AM  IoMT Becomes the Buzzword in New Age MedTech Investing Zacks
Sep-12-19 11:15PM  Dexcom Inc (DXCM) EVP CFO Quentin S. Blackford Sold $1.5 million of Shares GuruFocus.com
Sep-11-19 11:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $2.1 million of Shares GuruFocus.com
Sep-09-19 11:05AM  Dexcom G6® CGM System Now Available In Canada CNW Group -9.42%
Sep-06-19 09:25AM  Is DexCom, Inc. (NASDAQ:DXCM) Expensive For A Reason? A Look At Its Intrinsic Value Simply Wall St.
Sep-05-19 07:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $1.7 million of Shares GuruFocus.com
Sep-03-19 02:18PM  5 Internet of Things Stocks to Buy Now InvestorPlace
08:50AM  Here's Why You Should Hold on to DexCom (DXCM) Stock Now Zacks
Aug-31-19 07:29AM  Is Dexcom a Buy? Motley Fool
Aug-29-19 08:03AM  DexCom (DXCM) Scales 52-Week High: What's Driving the Stock? Zacks
Aug-27-19 04:22PM  The 52-Week Highs You Never Heard About InvestorPlace
Aug-23-19 04:25PM  Court Rules that the Patents Asserted against Dexcom CGM Systems are Invalid Business Wire
Aug-20-19 06:00AM  Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs Motley Fool
Aug-19-19 09:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $1.6 million of Shares GuruFocus.com
Aug-15-19 05:10PM  Edited Transcript of DXCM earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
05:09PM  Edited Transcript of DXCM earnings conference call or presentation 1-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
05:09PM  Edited Transcript of DXCM earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
01:55PM  Edited Transcript of DXCM earnings conference call or presentation 6-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
01:07PM  Edited Transcript of DXCM earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
01:06PM  Edited Transcript of DXCM earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 03:09PM  Why Insulet's Shares Are Rocketing 20.8% Higher Today Motley Fool
Aug-03-19 04:05PM  5 Top Medical Device Stocks to Buy Now Motley Fool
Aug-02-19 09:27AM  DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates Zacks
09:15AM  DexCom (DXCM) Hits 52-Week High, Can the Run Continue? Zacks
08:30AM  Dexcom Announces Upcoming Conference Presentations Business Wire
Aug-01-19 09:29AM  Does DexCom, Inc.'s (NASDAQ:DXCM) CEO Pay Matter? Simply Wall St. -5.45%
07:13AM  Dow Jones Futures: Three Stock Market Lessons From Wednesday's Sell-Off; 5 Stocks Moving On Earnings Investor's Business Daily
06:00AM  What You'll Want to Know About DexCom's Q2 Earnings Results Motley Fool
03:23AM  DexCom (DXCM) Q2 2019 Earnings Call Transcript Motley Fool
Jul-31-19 05:19PM  This Medtech Just Posted A Surprise Quarterly Gain So Why Did It Dive? Investor's Business Daily
04:03PM  Dexcom Reports Second Quarter 2019 Financial Results Business Wire
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
Jul-30-19 09:40AM  Medical Products' Earnings Roster for Jul 31: MCK, HOLX & More Zacks
Jul-25-19 07:37AM  What's in the Offing for DexCom's (DXCM) Earnings in Q2? Zacks
Jul-24-19 10:32AM  DexCom (DXCM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-16-19 06:00AM  FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars Reuters
Jul-15-19 10:00AM  3 Top Diabetes Stocks to Watch in July Motley Fool
Jul-12-19 01:06PM  3 Internet of Things Stocks to Buy for July Zacks
Jul-11-19 09:00AM  All You Need to Know About DexCom (DXCM) Rating Upgrade to Strong Buy Zacks
Jul-09-19 08:15PM  Dexcom Inc (DXCM) President, CEO and Chairman Kevin R Sayer Sold $877,500 of Shares GuruFocus.com
12:22PM  Profit from Surprise in Q2 2019 Earnings Season Zacks
Jul-05-19 09:25AM  Will MedTech Ease Investors' Concern & Outperform? 4 Picks Zacks
Jul-03-19 08:00AM  ETF & Stock Winners of Longest US Economic Expansion Zacks
Jul-02-19 09:00AM  Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time Business Wire
Jun-26-19 12:57PM  Need To Know: DexCom, Inc. (NASDAQ:DXCM) Insiders Have Been Selling Shares Simply Wall St.
Jun-21-19 04:10PM  IBD Stock Of The Day: Dexcom Nears Breakout On Medical Device Heyday Investor's Business Daily
Jun-17-19 05:52PM  Heres What Hedge Funds Think About DexCom, Inc. (DXCM) Insider Monkey
10:36AM  Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day Zacks
10:22AM  The Zacks Analyst Blog Highlights: JinkoSolar, Salem Media, Ciena, DexCom and Zumiez Zacks
Jun-14-19 01:27PM  3 "Internet of Things" Stocks to Buy Right Now Zacks
08:43AM  5 Top-Ranked Stocks Crushing the Market in June Zacks
08:09AM  Dexcom Looks Like It Can Finally Break Out on the Topside TheStreet.com
Jun-10-19 04:45PM  Why DexCom Stock Jumped Today Motley Fool +9.89%
Jun-07-19 08:26AM  DexCom and Companion Medical Collaboration to Support CGM Zacks
Jun-06-19 09:25AM  Here's Why You Should Invest in DexCom (DXCM) Stock Now Zacks
08:45AM  Dexcom and Companion Medical Announce Collaboration to Integrate Dexcom CGM Data and InPen Insulin Data Business Wire
May-31-19 03:51PM  Is DexCom's (NASDAQ:DXCM) 232% Share Price Increase Well Justified? Simply Wall St.
09:31AM  Why Is DexCom (DXCM) Down 0.4% Since Last Earnings Report? Zacks
May-15-19 02:21PM  3 "Internet of Things" Stocks to Buy Right Now Zacks
May-02-19 06:24PM  DexCom (DXCM) Q1 2019 Earnings Call Transcript Motley Fool
09:51AM  DexCom (DXCM) Beats on Q1 Earnings, Hikes '19 Guidance Zacks
May-01-19 05:25PM  DexCom (DXCM) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:16PM  DexCom: 1Q Earnings Snapshot Associated Press
04:02PM  Dexcom Reports First Quarter 2019 Financial Results Business Wire
11:46AM  DexCom Q1 Earnings Preview Benzinga
Apr-26-19 07:57AM  Jim Cramer Gives His Opinion On Sarepta, Blackstone, Tractor Supply And More Benzinga +5.12%
Apr-25-19 09:30PM  Cramer Remix: I think the stock market's biggest risk right now is the current IPO cycle CNBC
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AUGUSTINOS NICHOLASDirectorNov 07Sale185.291,208223,8306,854Nov 08 08:58 PM
SAYER KEVIN RPresident, CEO and ChairmanNov 04Sale157.5010,0001,575,017212,937Nov 06 06:20 PM
Pacelli Steven RobertEVP Strategy and Corporate DevOct 23Sale152.371,532233,43580,751Oct 25 04:35 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerOct 23Sale152.341,533233,53016,844Oct 25 04:35 PM
SAYER KEVIN RPresident, CEO and ChairmanOct 01Sale149.6010,0001,496,001222,937Oct 03 06:40 PM
ALTMAN STEVEN RDirectorOct 01Sale149.172,500372,91648,804Oct 03 06:40 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 24Sale155.002,016312,4820Sep 26 08:42 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 23Sale155.471,532238,18182,283Sep 25 07:37 PM
Balo Andrew K*Sep 18Sale151.462,386361,38457,916Sep 19 06:46 PM
AUGUSTINOS NICHOLASDirectorSep 16Sale145.491,208175,7528,062Sep 18 06:03 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 10Sale141.2510,3201,457,69169,754Sep 12 04:25 PM
MOY JEFFREYSVP OperationsSep 09Sale149.854,601689,47534,869Sep 11 09:45 PM
Balo Andrew K*Sep 09Sale151.569,1071,380,23460,302Sep 11 09:42 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 09Sale149.8611,6861,751,23280,074Sep 11 09:36 PM
ACE HEATHER SSVP Human ResourcesSep 09Sale151.226,415970,07352,676Sep 11 09:32 PM
Leach Jacob StevenEVP Chief Technology OfficerSep 09Sale149.864,712706,118111,105Sep 11 09:29 PM
Abbey DonaldEVP Quality and Regulatory AffSep 09Sale149.855,843875,59880,550Sep 11 09:30 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 09Sale149.855,843875,59466,821Sep 11 09:28 PM
Murphy Patrick MichaelSVP Legal AffairsSep 09Sale149.862,495373,89732,965Sep 11 09:28 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 09Sale149.865,843875,62083,815Sep 11 09:29 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 09Sale149.8614,3222,146,269232,937Sep 11 09:27 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 03Sale170.1310,0001,701,274247,259Sep 05 04:16 PM
Balo Andrew K*Sep 03Sale170.00376,29069,409Sep 05 04:16 PM
ACE HEATHER SSVP Human ResourcesAug 23Sale174.807,2431,266,06259,091Aug 26 09:12 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerAug 23Sale175.142,016353,0882,016Aug 26 09:12 PM
SAYER KEVIN RPresident, CEO and ChairmanAug 15Sale156.1210,0001,561,167278,100Aug 19 06:20 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJul 23Sale153.562,016309,5704,032Jul 24 06:15 PM
SAYER KEVIN RPresident, CEO and ChairmanJul 08Sale146.256,000877,476288,100Jul 09 06:57 PM
ALTMAN STEVEN RDirectorJul 01Sale151.622,500379,05251,304Jul 02 09:38 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJun 24Sale149.653,116466,30489,658Jun 25 05:21 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJun 24Sale149.622,016301,6266,048Jun 25 05:21 PM
AUGUSTINOS NICHOLASDirectorJun 14Sale146.321,208176,7559,270Jun 17 05:50 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 13Sale145.325,099741,008115,781Jun 14 05:32 PM
Murphy Patrick MichaelSVP Legal AffairsJun 10Sale127.0340050,81235,460Jun 11 06:12 PM
SAYER KEVIN RPresident, CEO and ChairmanJun 10Sale132.746,000796,444294,100Jun 11 06:12 PM
Balo Andrew K*Jun 05Sale125.007,825978,12569,392Jun 06 05:35 PM
Abbey DonaldEVP Quality and Regulatory AffJun 03Sale121.089,0301,093,35286,393Jun 04 05:37 PM
Blackford Quentin S.EVP Chief Financial OfficerMay 29Sale118.958,8741,055,52791,740May 30 04:56 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMay 23Sale117.292,016236,4528,064May 24 05:09 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMay 23Sale116.713,597419,81692,774May 24 05:09 PM
FOLETTA MARK GDirectorMay 15Sale121.891,000121,89513,095May 17 06:22 PM
SAYER KEVIN RPresident, CEO and ChairmanMay 13Sale115.736,000694,365300,100May 14 06:47 PM
Murphy Patrick MichaelSVP Legal AffairsMay 10Sale116.9240046,76835,860May 13 05:51 PM
Leach Jacob StevenEVP Chief Technology OfficerApr 24Option Exercise7.274,79734,874120,880Apr 25 06:06 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerApr 23Sale116.982,016235,83810,080Apr 24 07:58 PM
Pacelli Steven RobertEVP Strategy and Corporate DevApr 23Sale116.613,596419,32996,371Apr 24 07:58 PM
FOLETTA MARK GDirectorApr 15Sale118.981,000118,97714,095Apr 17 05:20 PM
SAYER KEVIN RPresident, CEO and ChairmanApr 15Sale118.916,000713,471306,100Apr 16 05:37 PM
Murphy Patrick MichaelSVP Legal AffairsApr 10Sale115.0540046,02036,260Apr 12 05:50 PM
ALTMAN STEVEN RDirectorApr 01Sale119.602,500298,99950,355Apr 02 07:09 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 25Sale127.382,016256,78912,096Mar 27 05:40 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 22Sale140.043,596503,57199,967Mar 26 06:25 PM
FOLETTA MARK GDirectorMar 15Sale150.281,000150,27915,095Mar 19 06:24 PM
Balo Andrew K*Mar 12Sale142.7910,9171,558,86277,217Mar 13 07:00 PM
Blackford Quentin S.EVP Chief Financial OfficerMar 12Sale142.795,358765,081100,614Mar 13 07:00 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 12Sale142.7910,8111,543,72672,570Mar 13 07:00 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 12Sale142.798,5551,221,587116,083Mar 13 07:00 PM
MOY JEFFREYSVP OperationsMar 12Sale142.798,5311,218,16027,358Mar 13 07:01 PM
Murphy Patrick MichaelSVP Legal AffairsMar 12Sale142.793,962565,74336,660Mar 13 07:01 PM
Abbey DonaldEVP Quality and Regulatory AffMar 12Sale142.797,6531,092,78995,423Mar 13 06:59 PM
ACE HEATHER SSVP Human ResourcesMar 12Sale142.795,793827,19566,334Mar 13 07:00 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 12Sale142.7910,8111,543,726103,913Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 12Sale142.7926,5663,793,418312,100Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 11Sale142.986,000857,890338,666Mar 13 07:01 PM
ACE HEATHER SSVP Human ResourcesMar 11Sale143.024,668667,63772,127Mar 13 07:00 PM
Murphy Patrick MichaelSVP Legal AffairsMar 08Sale141.5640056,62428,908Mar 11 08:46 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 22Sale144.671,667241,15799,737Feb 26 07:58 PM
FOLETTA MARK GDirectorFeb 15Sale148.721,000148,72316,095Feb 20 05:01 PM
SAYER KEVIN RPresident, CEO and ChairmanFeb 11Sale148.906,000893,400308,837Feb 13 07:23 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 04:46 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 09:24 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Sale149.743,114466,303101,404Jan 24 05:46 PM
KAHN BARBARADirectorJan 14Sale142.3010,6311,512,82716,817Jan 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanJan 14Sale140.996,000845,930314,837Jan 15 05:30 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffJan 10Sale138.7540055,50029,708Jan 14 09:42 PM
SKYLER JAY SDirectorJan 02Option Exercise4.5825,806118,19152,616Jan 04 05:03 PM
ALTMAN STEVEN RDirectorJan 02Sale117.042,500292,59352,855Jan 04 05:03 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerDec 21Sale109.341,510165,10114,112Dec 26 08:33 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 21Sale109.413,114340,700104,518Dec 26 08:22 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalDec 14Sale121.235,000606,16773,105Dec 18 06:34 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Option Exercise4.5811,16251,122331,999Dec 12 09:08 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffDec 10Sale121.9040048,76030,108Dec 12 09:09 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Sale121.6711,1621,358,041320,837Dec 12 09:08 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerNov 23Sale121.351,736210,66415,622Nov 27 06:27 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 23Sale121.423,114378,105107,632Nov 27 06:27 PM